Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment — California, December 2021–May 2022
Authors:
- Deborah E. MaldenDMDeborah E. Malden
- Vennis HongVHVennis Hong
- Bruno J. LewinBLBruno J. Lewin
- Bradley K. AckersonBABradley K. Ackerson
- Marc LipsitchMLMarc Lipsitch
- Joseph A. LewnardJLJoseph A. Lewnard
- Sara Y. TartofSTSara Y. Tartof
- 24 June 2022
- journal article
- research article
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 71 (25) , 830-833
Abstract
This report describes low rates of hospitalizations and emergency department visits after treatment with Paxlovid for COVID-19.Keywords
This publication has 3 references indexed in Scilit:
- Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk PatientsClinical Infectious Diseases, 2022
- Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19New England Journal of Medicine, 2022
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992